-
S1 - YCC - Invisible Killers: Pollution, Noise & Climate Stress on the Heart?
Done
-
S6 - BACTS & BSC Joint session - The tricuspid valve: how to manage it right?
Done
-
S24 - ESC BSC Joint session & Awards, 2025 ESC/EACTS Guidelines for the management of valvular heart disease
Done
-
S9 - BeHRA - Idiopathic VF: need for standardization
Done
-
S15 - BWGHF - Heart Failure in Women
Done
-
S4 - Keynote & Gold medal - Improving Cardiovascular Health In The EU: The Challenges Ahead
Done
-
S21 - BWGPC and Belgian Heart Ligue
Done
-
S25 - Council on Cardiogenomics - How to interpret a genetic report and manage the result?
Done
-
S12 - BWGA - Artificial Intelligence and cardiovascular diseases
Done
-
S28 - BIWAC - Mechanical complications after ACS: a multidisciplinary approach
Done
Christophe L. Dubois, MD, PhD.
Christophe Dubois was born on October 12, 1970, in Rocourt, Belgium. He is married with three
children. He received his MD from the Katholieke Universiteit of Leuven in 1995 with magna cum laude.
From 1995 to 1998, Prof. Dubois was a fellow in internal medicine at the Imelda Hospital of Bonheiden
and at the Gasthuisberg University Hospital of Leuven. From 1998 to 2001, he completed a fellowship
in cardiology at the Sint Jan Hospital of Genk and at the Gasthuisberg University Hospital of Leuven,
where he graduated as a cardiologist in 2001.
In 2001 Prof. Dubois joined the staff of the department of cardiovascular medicine of the Gasthuisberg
University Hospital. During his first years of practice he gained large experience in acute and
interventional cardiology. In 2003 he started fundamental research on the potential role of stem cells
in the regeneration of cardiac tissue following myocardial infarction, and received his PhD on this topic
in 2010. Simultaneously, he focused on complex coronary interventions in bifurcation lesions and the
left main coronary artery, and was site principal investigator of numerous clinical trials. In 2008 he set
up a percutaneous heart valve program together with his surgical colleagues. To date, he is serving as
clinical head of the department of cardiovascular medicine at the University Hospital of Leuven and
professor at the faculty of medicine and biomedical sciences of the University of Leuven.
Prof. Dubois has published multiple papers and abstracts in influent peer-reviewed journals as the New
England Journal of Medicine, Journal of the American College of Cardiology, Lancet, European Heart
Journal, International Journal of Cardiology, EuroIntervention, American Journal of Cardiology,
Catheterization and Cardiovascular Interventions and Heart.
Prof. Dubois is Fellow of the European Society of Cardiology and President of the Belgian Working
Group on Interventional Cardiology. He also serves as steering committee member of the European
Structural Heart Diseases Coalition.
More information soon
Dr. Carlo Zivelonghi is an accomplished interventional cardiologist with broad international educational and professional experience. He completed his medical training at the University of Verona in Verona, Italy, with a subsequent specialitation in cardiology in 2018. He started his early research and cathlab career in the Biomedical Research Unit at Royal Brompton Hospital in London in 2013. At the end of his cardiology training, he spent more than year in the prestigious Sint Antonius Hospital, Utrecht (the Netherlands) for additional clinical research and cathlab activities. Dr Zivelonghi earned a doctorate in Cardiovascular Sciences from the prestigious University of Amsterdam with a thesis on complex interventional procedures for refractory angina. He moved to Antwerp in Belgium to formally conclude his training in interventional cardiology at the renowned Hartcentrum ZNA Middelheim Hospital, where he is still working as invasive cardiologist and, with more than 100 peer-reviewed publications, he serves also as coordinator of the Research and Development department.
Rapid atrial pacing as a predictor of permanent pacemaker implantation post-TAVI: the PACE TAVI study
Emmanuel De Cock is an interventional cardiologist at AZ Sint-Jan Bruges. He has a special interest in structural heart interventions, complex coronary interventions, and chronic total occlusion (CTO) procedures. He is currently pursuing a PhD on the role of colchicine in secondary prevention after PCI within the COL BE PCI trial, a Belgian initiative running across 22 sites nationwide."
